Gazyva

药品简介

Originator: Gazyva by Genentech, Inc. · Manufacturer: Roche Pharma. Indication & Dosage: Gazyva (Obinutuzumab), is a prescription medicine used to treat of specific hematologic malignancies, including chronic lymphocytic leukemia and follicular lymphoma. As a monoclonal antibody, it targets the CD20 protein on B cells, thereby inhibiting the growth and survival of cancerous cells. Gazyva manufacturted by Roche Bangladesh Ltd. In Bangladesh. Obinutuzumab is given by injection into a vein by a health care professional. It is given as directed by patient’s doctor, usually once certain days each month. Side Effects: The most common side effects of Obinutuzumab are: Infusion-related reactions, Fatigue, Nausea, Fever, Cough, Diarrhea, Anemia, Infections (e.g., respiratory, urinary), Thrombocytopenia, Neutropenia. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。